- Ohio university quiz implies atheists are naturally smarter than Christians
- Rep. Henry Cuellar on border crisis: ‘Playing defense on the one-yard line’
- Activists vow to occupy fast-food restaurants to get higher pay
- Rep. Luis Gutierrez: Senate Dems wary of immigration politics
- Summer camp for 1 percenters: Sushi, limos and shopping at FAO Schwarz
- Colorado gun crackdown law found to be built on faulty data
- Hank Aaron steps to fundraising plate for Democrat Michelle Nunn
- ISIL terrorists blow up burial site of Jonah, vow more of same
- Impeach Obama, say 35 percent in new poll
- Taliban yank 14 Shiites off bus, bind and shoot them on Afghan road
Czech chemist Antonin Holy dies at 75
Question of the Day
PRAGUE (AP) - Antonin Holy, a renowned Czech scientist whose research significantly contributed to the development of antiviral drugs, has died, his long-time research institute said Tuesday.
Prague's Institute of Organic Chemistry and Biochemistry of the Academy of Sciences where Holy has been working since 1960 says he died Monday after battling an unspecified long-term disease. He was 75.
He died the same day the U.S. Food and Drug Administration approved a drug Holy helped to create.
Truvada, which is made by the U.S. pharmaceutical company Gilead Sciences, is the first drug shown to reduce the risk of HIV infection. It is intended to be taken as a preventive measure for healthy people who are at high risk of acquiring HIV through sexual activity, such as those who have HIV-infected partners.
Holy, a research professor of nucleic acid chemistry, helped discover substances that are part of current-day drugs, such as Viread and Vistide, which are used for treatment of HIV-infected patients, and Hepsera, that is used in the treatment of hepatitis B.
Holy has more than 60 patents to his name and is an author of some 600 scientific papers. Since 1976, he worked closely with professor Erik De Clercq from the Leuven University, Belgium.
In 2002, Holy received the EU Descartes Award for Scientific research and holds honorary degrees from several universities at home and abroad.
Gilead Sciences, which is based in Foster City, California donated $1.1 million a year, starting in 2006 to his institute to fund Holy's research.
Holy was born Sept 1, 1936 in Prague and only retired a year ago.
"Science is a real hard work," Holy said.
His institute called his death "an immense loss."
TWT Video Picks
Second- and third-stringers eye 2016 if front-runner stumbles
- Michelle Obama says money in politics is bad, asks donors for 'big, fat check'
- Presidents of Honduras, Guatemala blame U.S. for border children crisis
- 'We're coming for you, Barack Obama': Top U.S. official discloses threat from ISIL terrorists
- EDITORIAL: Detroit's water 'spigot bigots'
- NAPOLITANO: What if our democracy is a fraud?
- Hamas rejects Kerry's call for cease-fire; Fears grow others could join fight against Israel
- Crime-ridden U.S. cities differ on ways to fight gun violence
- Obama takes aim at 'corporate deserters'
- Let it roll: D.C. Council hits Las Vegas on taxpayer's dime, leaves $14,000 tab
- Obama orders Pentagon advisers to Ukraine
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world
Fighting in Iraq